New insights into the immune molecular regulation of the pathogenesis of acute respiratory distress syndrome

International Journal of Molecular Sciences

Volumn 19, Issue 2, 2018, Pages

  Yang, Chin Yao ^a   Chen, Chien Sheng ^b,c   Yiang, Giou Teng ^b,c   Cheng, Yeung Leung ^b,c   Yong, Su Boon ^d,e,f   Wu, Meng Yu ^b,c   Li, Chia Jung ^e  

^a KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b TAIPEI TZU CHI HOSPITAL   (Taiwan)

^c TZU CHI UNIVERSITY   (Taiwan)

^d CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^e SHOW CHWAN MEMORIAL HOSPITAL   (Taiwan)

^f MEIHO UNIVERSITY   (Taiwan)

Author keywords

Acute respiratory distress syndrome; NETosis; Sepsis; Vascular permeability

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; ANGIOTENSIN; CLAUDIN; CORTICOSTEROID; FAS LIGAND; HISTAMINE; INTERLEUKIN 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MAMMALIAN TARGET OF RAPAMYCIN; PROSTAGLANDIN; PROTEINASE; REACTIVE OXYGEN METABOLITE; RHO FACTOR; RHO KINASE; SPHINGOSINE 1 PHOSPHATE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 12; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNINDEXED DRUG; VASCULAR ENDOTHELIAL GROWTH INHIBITOR; VASCULOTROPIN; VASCULOTROPIN RECEPTOR; VASODILATOR AGENT;

ADULT RESPIRATORY DISTRESS SYNDROME; ANTIGEN PRESENTING CELL; B LYMPHOCYTE; BLOOD VESSEL PERMEABILITY; CLINICAL FEATURE; HUMAN; IMMUNE RESPONSE; INFLAMMATION; INTRACELLULAR SIGNALING; LUNG ALVEOLUS MACROPHAGE; MICROENVIRONMENT; MOLECULAR PATHOLOGY; NEUROMUSCULAR BLOCKING; NEUTROPHIL; NONHUMAN; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; T LYMPHOCYTE; VASCULAR ENDOTHELIAL BARRIER; ANIMAL; CAPILLARY PERMEABILITY; IMMUNOLOGY; METABOLISM; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM;

ANIMALS; CAPILLARY PERMEABILITY; ENDOTHELIUM, VASCULAR; HUMANS; RESPIRATORY DISTRESS SYNDROME, ADULT; SIGNAL TRANSDUCTION;

EID: 85042226638     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms19020588     Document Type: Review

References (135)

1. Lee, K.Y. Pneumonia, Acute Respiratory Distress Syndrome, and Early Immune-Modulator Therapy. Int. J. Mol. Sci. 2017, 18, 388.
2. Ashbaugh, D.G.; Bigelow, D.B.; Petty, T.L.; Levine, B.E. Acute respiratory distress in adults. Lancet 1967, 2, 319–323.
3. Abrams, D.; Brodie, D. Extracorporeal membrane oxygenation for adult respiratory failure: 2017 update. Chest 2017, 152, 639–649.
4. Confalonieri, M.; Salton, F.; Fabiano, F. Acute respiratory distress syndrome. Eur. Respir. Rev. 2017, 26, doi:10.1183/16000617.0116-2016.
5. Epelbaum, O.; Aronow, W.S. Mechanical ventilation in the acute respiratory distress syndrome. Hosp. Pract. 2017, 45, 88–98.
6. Matthay, M.A.; McAuley, D.F.; Ware, L.B. Clinical trials in acute respiratory distress syndrome: Challenges and opportunities. Lancet Respir. Med. 2017, 5, 524–534.
7. Meyer, N.J.; Calfee, C.S. Novel translational approaches to the search for precision therapies for acute respiratory distress syndrome. Lancet Respir. Med. 2017, 5, 512–523.
8. Brower, R.G.; Lanken, P.N.; MacIntyre, N.; Matthay, M.A.; Morris, A.; Ancukiewicz, M.; Schoenfeld, D.; Thompson, B.T. Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. N. Engl. J. Med. 2004, 351, 327–336.
9. Esteban, A.; Frutos-Vivar, F.; Muriel, A.; Ferguson, N.D.; Penuelas, O.; Abraira, V.; Raymondos, K.; Rios, F.; Nin, N.; Apezteguia, C.; et al. Evolution of mortality over time in patients receiving mechanical ventilation. Am. J. Respir. Crit. Care Med. 2013, 188, 220–230.
10. Villar, J.; Blanco, J.; Anon, J.M.; Santos-Bouza, A.; Blanch, L.; Ambros, A.; Gandia, F.; Carriedo, D.; Mosteiro, F.; Basaldua, S.; et al. The Alien study: Incidence and outcome of acute respiratory distress syndrome in the era of lung protective ventilation. Intensive Care Med. 2011, 37, 1932–1941.
11. Wang, C.Y.; Calfee, C.S.; Paul, D.W.; Janz, D.R.; May, A.K.; Zhuo, H.; Bernard, G.R.; Matthay, M.A.; Ware, L.B.; Kangelaris, K.N. One-year mortality and predictors of death among hospital survivors of acute respiratory distress syndrome. Intensive Care Med. 2014, 40, 388–396.
12. Bellani, G.; Laffey, J.G.; Pham, T.; Fan, E.; Brochard, L.; Esteban, A.; Gattinoni, L.; van Haren, F.; Larsson, A.; McAuley, D.F.; et al. Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA 2016, 315, 788–800.
13. Bersten, A.D.; Edibam, C.; Hunt, T.; Moran, J. Incidence and mortality of acute lung injury and the acute respiratory distress syndrome in three Australian states. Am. J. Respir. Crit. Care Med. 2002, 165, 443–448.
14. Estenssoro, E.; Dubin, A.; Laffaire, E.; Canales, H.; Saenz, G.; Moseinco, M.; Pozo, M.; Gomez, A.; Baredes, N.; Jannello, G.; et al. Incidence, clinical course, and outcome in 217 patients with acute respiratory distress syndrome. Crit. Care Med. 2002, 30, 2450–2456.
15. MacCallum, N.S.; Evans, T.W. Epidemiology of acute lung injury. Curr. Opin. Crit. Care 2005, 11, 43–49.
16. Rubenfeld, G.D.; Caldwell, E.; Peabody, E.; Weaver, J.; Martin, D.P.; Neff, M.; Stern, E.J.; Hudson, L.D. Incidence and outcomes of acute lung injury. N. Engl. J. Med. 2005, 353, 1685–1693.
17. Kim, W.Y.; Hong, S.B. Sepsis and acute respiratory distress syndrome: Recent update. Tuberc. Respir. Dis. (Seoul) 2016, 79, 53–57.
18. Hudson, L.D.; Milberg, J.A.; Anardi, D.; Maunder, R.J. Clinical risks for development of the acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 1995, 151, 293–301.
19. Fanelli, V.; Vlachou, A.; Ghannadian, S.; Simonetti, U.; Slutsky, A.S.; Zhang, H. Acute respiratory distress syndrome: New definition, current and future therapeutic options. J. Thoracic Dis. 2013, 5, 326–334.
20. Bernard, G.R.; Artigas, A.; Brigham, K.L.; Carlet, J.; Falke, K.; Hudson, L.; Lamy, M.; Legall, J.R.; Morris, A.; Spragg, R. The American-European consensus conference on Ards. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am. J. Respir. Crit. Care Med. 1994, 149, 818–824.
21. Ferguson, N.D.; Fan, E.; Camporota, L.; Antonelli, M.; Anzueto, A.; Beale, R.; Brochard, L.; Brower, R.; Esteban, A.; Gattinoni, L.; et al. The Berlin definition of Ards: An expanded rationale, justification, and supplementary material. Intensive Care Med. 2012, 38, 1573–1582.
22. Walkey, A.J.; Summer, R.; Ho, V.; Alkana, P. Acute respiratory distress syndrome: Epidemiology and management approaches. Clin. Epidemiol. 2012, 4, 159–169.
23. Greco, E.; Lupia, E.; Bosco, O.; Vizio, B.; Montrucchio, G. Platelets and multi-organ failure in sepsis. Int. J. Mol. Sci. 2017, 18, 2200.
24. Koh, Y. Update in acute respiratory distress syndrome. J. Intensive Care 2014, 2, 2.
25. Sharp, C.; Millar, A.B.; Medford, A.R. Advances in understanding of the pathogenesis of acute respiratory distress syndrome. Respiration 2015, 89, 420–434.
26. Ware, L.B.; Matthay, M.A. The acute respiratory distress syndrome. N. Engl. J. Med. 2000, 342, 1334–1349.
27. Wu, M.-Y.; Li, C.-J.; Hou, M.-F.; Chu, P.-Y. New insights into the role of inflammation in the pathogenesis of atherosclerosis. Int. J. Mol. Sci. 2017, 18, 2034.
28. Chavez, A.; Smith, M.; Mehta, D. Chapter six—New insights into the regulation of vascular permeability. In International Review of Cell and Molecular Biology; Jeon, K.W., Ed.; Academic Press: Cambridge, MA, USA, 2011; Volume 290, pp. 205–248.
29. Fujishima, S. Pathophysiology and biomarkers of acute respiratory distress syndrome. J. Intensive Care 2014, 2, 32.
30. Garcia, J.G. Concepts in microvascular endothelial barrier regulation in health and disease. Microvasc. Res. 2009, 77, 1–3.
31. Eklund, L.; Saharinen, P. Angiopoietin signaling in the vasculature. Exp. Cell Res. 2013, 319, 1271–1280.
32. Wang, L.; Dudek, S.M. Regulation of vascular permeability by sphingosine 1-phosphate. Microvasc. Res. 2009, 77, 39–45.
33. Kendrick, S.F.W.; Jones, D.E.J. Mechanisms of innate immunity in sepsis. In Sepsis; Baudouin, S.V., Ed.; Springer: London, UK, 2008; pp. 5–10.
34. Remick, D.G. Pathophysiology of sepsis. Am. J. Pathol. 2007, 170, 1435–1444.
35. Barratt, S.; Medford, A.R.; Millar, A.B. Vascular endothelial growth factor in acute lung injury and acute respiratory distress syndrome. Respiration 2014, 87, 329–342.
36. Azamfirei, L.; Gurzu, S.; Solomon, R.; Copotoiu, R.; Copotoiu, S.; Jung, I.; Tilinca, M.; Branzaniuc, K.; Corneci, D.; Szederjesi, J.; et al. Vascular endothelial growth factor: A possible mediator of endothelial activation in acute respiratory distress syndrome. Minerva Anestesiol. 2010, 76, 609–616.
37. Ourradi, K.; Blythe, T.; Jarrett, C.; Barratt, S.L.; Welsh, G.I.; Millar, A.B. Vegf isoforms have differential effects on permeability of human pulmonary microvascular endothelial cells. Respir. Res. 2017, 18, 116.
38. Matute-Bello, G.; Liles, W.C.; Steinberg, K.P.; Kiener, P.A.; Mongovin, S.; Chi, E.Y.; Jonas, M.; Martin, T.R. Soluble fas ligand induces epithelial cell apoptosis in humans with acute lung injury (Ards). J. Immunol. 1999, 163, 2217–2225.
39. Galani, V.; Tatsaki, E.; Bai, M.; Kitsoulis, P.; Lekka, M.; Nakos, G.; Kanavaros, P. The role of apoptosis in the pathophysiology of acute respiratory distress syndrome (Ards): An up-to-date cell-specific review. Pathol. Res. Pract. 2010, 206, 145–150.
40. Fialkow, L.; Fochesatto Filho, L.; Bozzetti, M.C.; Milani, A.R.; Rodrigues Filho, E.M.; Ladniuk, R.M.; Pierozan, P.; de Moura, R.M.; Prolla, J.C.; Vachon, E.; et al. Neutrophil apoptosis: A marker of disease severity in sepsis and sepsis-induced acute respiratory distress syndrome. Crit. Care 2006, 10, R155.
41. Pan, L.; Yao, D.C.; Yu, Y.Z.; Li, S.J.; Chen, B.J.; Hu, G.H.; Xi, C.; Wang, Z.H.; Wang, H.Y.; Li, J.H.; et al. Necrostatin-1 protects against Oleic acid-induced acute respiratory distress syndrome in rats. Biochem. Biophys. Res. Commun. 2016, 478, 1602–1608.
42. Qing, D.Y.; Conegliano, D.; Shashaty, M.G.; Seo, J.; Reilly, J.P.; Worthen, G.S.; Huh, D.; Meyer, N.J.; Mangalmurti, N.S. Red blood cells induce necroptosis of lung endothelial cells and increase susceptibility to lung inflammation. Am. J. Respir. Crit. Care Med. 2014, 190, 1243–1254.
43. Wang, L.; Wang, T.; Li, H.; Liu, Q.; Zhang, Z.; Xie, W.; Feng, Y.; Socorburam, T.; Wu, G.; Xia, Z.; et al. Receptor interacting protein 3-mediated necroptosis promotes lipopolysaccharide-induced inflammation and acute respiratory distress syndrome in mice. PLoS ONE 2016, 11, e0155723.
44. Burnham, E.L.; Janssen, W.J.; Riches, D.W.H.; Moss, M.; Downey, G.P. The fibroproliferative response in acute respiratory distress syndrome: Mechanisms and clinical significance. Eur. Respir. J. 2014, 43, 276–285.
45. Hamada, N.; Kuwano, K.; Yamada, M.; Hagimoto, N.; Hiasa, K.; Egashira, K.; Nakashima, N.; Maeyama, T.; Yoshimi, M.; Nakanishi, Y. Anti-vascular endothelial growth factor gene therapy attenuates lung injury and fibrosis in mice. J. Immunol. 2005, 175, 1224–1231.
46. Keane, M.P.; Belperio, J.A.; Moore, T.A.; Moore, B.B.; Arenberg, D.A.; Smith, R.E.; Burdick, M.D.; Kunkel, S.L.; Strieter, R.M. Neutralization of the Cxc chemokine, macrophage inflammatory protein-2, attenuates bleomycin-induced pulmonary fibrosis. J. Immunol. 1999, 162, 5511–5518.
47. Ou, X.M.; Li, W.C.; Liu, D.S.; Li, Y.P.; Wen, F.Q.; Feng, Y.L.; Zhang, S.F.; Huang, X.Y.; Wang, T.; Wang, K.; et al. Vegfr-2 antagonist Su5416 attenuates bleomycin-induced pulmonary fibrosis in mice. Int. Immunopharmacol. 2009, 9, 70–79.
48. Parikh, S.M.; Mammoto, T.; Schultz, A.; Yuan, H.T.; Christiani, D.; Karumanchi, S.A.; Sukhatme, V.P. Excess circulating angiopoietin-2 may contribute to pulmonary vascular leak in sepsis in humans. PLoS Med. 2006, 3, e46.
49. Network, T.A.R.D.S. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N. Engl. J. Med. 2000, 342, 1301–1308.
50. Tremblay, L.N.; Slutsky, A.S. Ventilator-induced lung injury: From the bench to the bedside. Intensive Care Med. 2006, 32, 24–33.
51. Pelosi, P.; Rocco, P.R. Effects of Mechanical Ventilation on the Extracellular Matrix. Intensive Care Med 2008, 34, 631–639.
52. Tremblay, L.N.; Miatto, D.; Hamid, Q.; Govindarajan, A.; Slutsky, A.S. Injurious ventilation induces widespread pulmonary epithelial expression of tumor necrosis factor-alpha and interleukin-6 messenger RNA. Crit. Care Med. 2002, 30, 1693–1700.
53. Capelozzi, V.L.; Allen, T.C.; Beasley, M.B.; Cagle, P.T.; Guinee, D.; Hariri, L.P.; Husain, A.N.; Jain, D.; Lantuejoul, S.; Larsen, B.T.; et al. Molecular and immune biomarkers in acute respiratory distress syndrome: A perspective from members of the pulmonary pathology society. Arch. Pathol. Lab. Med. 2017, 141, 1719–1727.
54. Aggarwal, N.R.; King, L.S.; D’Alessio, F.R. Diverse macrophage populations mediate acute lung inflammation and resolution. Am. J. Physiol. Lung Cell Mol. Physiol. 2014, 306, L709–L725.
55. Han, S.H.; Mallampalli, R.K. The acute respiratory distress syndrome: From mechanism to translation. J. Immunol. 2015, 194, 855–860.
56. D’Alessio, F.R.; Craig, J.M.; Singer, B.D.; Files, D.C.; Mock, J.R.; Garibaldi, B.T.; Fallica, J.; Tripathi, A.; Mandke, P.; Gans, J.H.; et al. Enhanced resolution of experimental Ards through Il-4-mediated lung macrophage reprogramming. Am. J. Physiol. Lung Cell Mol. Physiol. 2016, 310, L733–L746.
57. Norman, J.G.; Fink, G.W.; Franz, M.G. Acute pancreatitis induces intrapancreatic tumor necrosis factor gene expression. Arch. Surg. 1995, 130, 966–970.
58. Cohen, J. The immunopathogenesis of sepsis. Nature 2002, 420, 885–891.
59. Wrigge, H.; Stüber, F.; Putensen, C. Ventilator-associated systemic inflammation. In Yearbook of Intensive Care and Emergency Medicine 2001; Vincent, J.-L., Ed.; Springer: Berlin/Heidelberg, Germany, 2001; pp. 35–43.
60. Park, W.Y.; Goodman, R.B.; Steinberg, K.P.; Ruzinski, J.T.; Radella, F., 2nd; Park, D.R.; Pugin, J.; Skerrett, S.J.; Hudson, L.D.; Martin, T.R. Cytokine balance in the lungs of patients with acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 2001, 164, 1896–1903.
61. Siler, T.M.; Swierkosz, J.E.; Hyers, T.M.; Fowler, A.A.; Webster, R.O. Immunoreactive interleukin-1 in bronchoalveolar lavage fluid of high-risk patients and patients with the adult respiratory distress syndrome. Exp. Lung Res. 1989, 15, 881–894.
62. Giri, S.N.; Hyde, D.M.; Hollinger, M.A. Effect of antibody to transforming growth factor beta on bleomycin induced accumulation of lung collagen in mice. Thorax 1993, 48, 959–966.
63. Ihn, H. Pathogenesis of fibrosis: Role of Tgf-Beta and Ctgf. Curr. Opin. Rheumatol. 2002, 14, 681–685.
64. Shull, M.M.; Ormsby, I.; Kier, A.B.; Pawlowski, S.; Diebold, R.J.; Yin, M.; Allen, R.; Sidman, C.; Proetzel, G.; Calvin, D.; et al. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 1992, 359, 693–699.
65. Broekelmann, T.J.; Limper, A.H.; Colby, T.V.; McDonald, J.A. Transforming growth factor beta 1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis. Proc. Natl. Acad. Sci. USA 1991, 88, 6642–6646.
66. Howard, M.; O’Garra, A. Biological properties of interleukin 10. Immunol. Today 1992, 13, 198–200.
67. Smith, S.R.; Terminelli, C.; Kenworthy-Bott, L.; Calzetta, A.; Donkin, J. The cooperative effects of Tnf-alpha and Ifn-gamma are determining factors in the ability of Il-10 to protect mice from lethal endotoxemia. J. Leukoc. Biol. 1994, 55, 711–718.
68. Fiorentino, D.F.; Zlotnik, A.; Mosmann, T.R.; Howard, M.; O’Garra, A. Il-10 inhibits cytokine production by activated macrophages. J. Immunol. 1991, 147, 3815–3822.
69. Kasama, T.; Strieter, R.M.; Lukacs, N.W.; Burdick, M.D.; Kunkel, S.L. Regulation of neutrophil-derived chemokine expression by Il-10. J. Immunol. 1994, 152, 3559–3569.
70. Lo, C.-J.; Fu, M.; Cryer, H.G. Interleukin 10 inhibits alveolar macrophage production of inflammatory mediators involved in adult respiratory distress syndrome. J. Surg. Res. 1998, 79, 179–184.
71. Armstrong, L.; Millar, A.B. Relative production of tumour necrosis factor alpha and interleukin 10 in adult respiratory distress syndrome. Thorax 1997, 52, 442–446.
72. Miller, E.J.; Cohen, A.B.; Nagao, S.; Griffith, D.; Maunder, R.J.; Martin, T.R.; Weiner-Kronish, J.P.; Sticherling, M.; Christophers, E.; Matthay, M.A. Elevated levels of nap-1/interleukin-8 are present in the airspaces of patients with the adult respiratory distress syndrome and are associated with increased mortality. Am. Rev. Respir. Dis. 1992, 146, 427–432.
73. Olson, T.S.; Ley, K. Chemokines and chemokine receptors in leukocyte trafficking. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2002, 283, R7–R28.
74. Puneet, P.; Moochhala, S.; Bhatia, M. Chemokines in acute respiratory distress syndrome. Am. J. Physiol. Lung Cell Mol. Physiol. 2005, 288, L3–L15.
75. Cummings, C.J.; Martin, T.R.; Frevert, C.W.; Quan, J.M.; Wong, V.A.; Mongovin, S.M.; Hagen, T.R.; Steinberg, K.P.; Goodman, R.B. Expression and function of the chemokine receptors Cxcr1 and Cxcr2 in sepsis. J. Immunol. 1999, 162, 2341–2346.
76. Chishti, A.D.; Dark, J.H.; Kesteven, P.; Powell, H.; Snowden, C.; Shenton, B.K.; Kirby, J.A.; Baudouin, S.V. Expression of chemokine receptors Cxcr1 and Cxcr2 during cardiopulmonary bypass. J. Thoracic Cardiovasc. Surg. 2001, 122, 1162–1166.
77. Stillie, R.; Farooq, S.M.; Gordon, J.R.; Stadnyk, A.W. The functional significance behind expressing two Il-8 receptor types on Pmn. J. Leukoc. Biol. 2009, 86, 529–543.
78. Summers, C.; Singh, N.R.; White, J.F.; Mackenzie, I.M.; Johnston, A.; Solanki, C.; Balan, K.K.; Peters, A.M.; Chilvers, E.R. Pulmonary retention of primed neutrophils: A novel protective host response, which is impaired in the acute respiratory distress syndrome. Thorax 2014, 69, 623–629.
79. Grommes, J.; Soehnlein, O. Contribution of neutrophils to acute lung injury. Mol. Med. 2011, 17, 293–307.
80. Buczek-Thomas, J.A.; Lucey, E.C.; Stone, P.J.; Chu, C.L.; Rich, C.B.; Carreras, I.; Goldstein, R.H.; Foster, J.A.; Nugent, M.A. Elastase mediates the release of growth factors from lung in vivo. Am. J. Respir. Cell Mol. Biol. 2004, 31, 344–350.
81. Suzuki, T.; Yamashita, C.; Zemans, R.L.; Briones, N.; Van Linden, A.; Downey, G.P. Leukocyte elastase induces lung epithelial apoptosis via a Par-1–, Nf-κb–, and P53-dependent pathway. Am. J. Respir. Cell Mol. Biol. 2009, 41, 742–755.
82. Chen, H.C.; Lin, H.C.; Liu, C.Y.; Wang, C.H.; Hwang, T.; Huang, T.T.; Lin, C.H.; Kuo, H.P. Neutrophil elastase induces Il-8 synthesis by lung epithelial cells via the mitogen-activated protein kinase pathway. J. Biomed. Sci. 2004, 11, 49–58.
83. Witherden, I.R.; Vanden Bon, E.J.; Goldstraw, P.; Ratcliffe, C.; Pastorino, U.; Tetley, T.D. Primary human alveolar type II epithelial cell chemokine release: Effects of cigarette smoke and neutrophil elastase. Am. J. Respir. Cell Mol. Biol. 2004, 30, 500–509.
84. Kaplan, M.J. Neutrophil extracellular traps (nets): Double-edged swords of innate immunity. J. Immunol. 2012, 189, 2689–2695.
85. Brinkmann, V.; Reichard, U.; Goosmann, C.; Fauler, B.; Uhlemann, Y.; Weiss, D.S.; Weinrauch, Y.; Zychlinsky, A. Neutrophil extracellular traps kill bacteria. Science 2004, 303, 1532–1535.
86. Dejana, E. Endothelial cell-cell junctions: Happy together. Nat. Rev. Mol. Cell Biol. 2004, 5, 261–270.
87. Wennerberg, K.; Rossman, K.L.; Der, C.J. The ras superfamily at a glance. J. Cell Sci. 2005, 118, 843–846.
88. Bustelo, X.R.; Sauzeau, V.; Berenjeno, I.M. Gtp-binding proteins of the Rho/Rac family: Regulation, effectors and functions in vivo. Bioessays 2007, 29, 356–370.
89. Medzhitov, R. Toll-like receptors and innate immunity. Nat. Rev. Immunol. 2001, 1, 135–145.
90. Amano, M.; Nakayama, M.; Kaibuchi, K. Rho-kinase/rock: A key regulator of the cytoskeleton and cell polarity. Cytoskeleton 2010, 67, 545–554.
91. Sawafuji, M.; Ishizaka, A.; Kohno, M.; Koh, H.; Tasaka, S.; Ishii, Y.; Kobayashi, K. Role of rho-kinase in reexpansion pulmonary edema in rabbits. Am. J. Physiol. Lung Cell Mol. Physiol. 2005, 289, L946–L953.
92. Paszti-Gere, E.; Csibrik-Nemeth, E.; Szeker, K.; Csizinszky, R.; Jakab, C.; Galfi, P. Acute oxidative stress affects Il-8 and Tnf-alpha expression in Ipec-J2 porcine epithelial cells. Inflammation 2012, 35, 994–1004.
93. Soini, Y. Claudins in lung diseases. Respir. Res. 2011, 12, 70.
94. Overgaard, C.E.; Daugherty, B.L.; Mitchell, L.A.; Koval, M. Claudins: Control of barrier function and regulation in response to oxidant stress. Antioxid. Redox. Signal. 2011, 15, 1179–1193.
95. Figueira, E.R.; Bacchella, T.; Coelho, A.M.; Sampietre, S.N.; Molan, N.A.; Leitao, R.M.; Machado, M.C. Timing-dependent protection of hypertonic saline solution administration in experimental liver ischemia/reperfusion injury. Surgery 2010, 147, 415–423.
96. Lucas, R.; Verin, A.D.; Black, S.M.; Catravas, J.D. Regulators of endothelial and epithelial barrier integrity and function in acute lung injury. Biochem. Pharmacol. 2009, 77, 1763–1772.
97. Rokkam, D.; Lafemina, M.J.; Lee, J.W.; Matthay, M.A.; Frank, J.A. Claudin-4 levels are associated with intact alveolar fluid clearance in human lungs. Am. J. Pathol. 2011, 179, 1081–1087.
98. Montgomery, A.B.; Stager, M.A.; Carrico, C.J.; Hudson, L.D. Causes of mortality in patients with the adult respiratory distress syndrome. Am. Rev. Respir. Dis. 1985, 132, 485–489.
99. Bell, R.C.; Coalson, J.J.; Smith, J.D.; Johanson, W.G., Jr. Multiple organ system failure and infection in adult respiratory distress syndrome. Ann. Internal Med. 1983, 99, 293–298.
100. Anzueto, A.; Baughman, R.P.; Guntupalli, K.K.; Weg, J.G.; Wiedemann, H.P.; Raventos, A.A.; Lemaire, F.; Long, W.; Zaccardelli, D.S.; Pattishall, E.N. Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome. Exosurf acute respiratory distress syndrome sepsis study group. N. Engl. J. Med. 1996, 334, 1417–1421.
101. Khilnani, G.; Hadda, V. Corticosteroids and Ards: A review of treatment and prevention evidence. Lung India 2011, 28, 114–119.
102. Taylor, R.W.; Zimmerman, J.L.; Dellinger, R.P.; Straube, R.C.; Criner, G.J.; Davis, K., Jr.; Kelly, K.M.; Smith, T.C.; Small, R.J. Low-dose inhaled nitric oxide in patients with acute lung injury: A randomized controlled trial. JAMA 2004, 291, 1603–1609.
103. Milberg, J.A.; Davis, D.R.; Steinberg, K.P.; Hudson, L.D. Improved survival of patients with acute respiratory distress syndrome (Ards): 1983–1993. JAMA 1995, 273, 306–309.
104. Abel, S.J.; Finney, S.J.; Brett, S.J.; Keogh, B.F.; Morgan, C.J.; Evans, T.W. Reduced mortality in association with the acute respiratory distress syndrome (Ards). Thorax 1998, 53, 292–294.
105. Needham, D.M.; Colantuoni, E.; Mendez-Tellez, P.A.; Dinglas, V.D.; Sevransky, J.E.; Dennison Himmelfarb, C.R.; Desai, S.V.; Shanholtz, C.; Brower, R.G.; Pronovost, P.J. Lung protective mechanical ventilation and two year survival in patients with acute lung injury: Prospective cohort study. BMJ 2012, 344, e2124.
106. Manzano, F.; Fernandez-Mondejar, E.; Colmenero, M.; Poyatos, M.E.; Rivera, R.; Machado, J.; Catalan, I.; Artigas, A. Positive-end expiratory pressure reduces incidence of ventilator-associated pneumonia in nonhypoxemic patients. Crit. Care Med. 2008, 36, 2225–2231.
107. Gattinoni, L.; Pelosi, P.; Crotti, S.; Valenza, F. Effects of positive end-expiratory pressure on regional distribution of tidal volume and recruitment in adult respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 1995, 151, 1807–1814.
108. Caironi, P.; Cressoni, M.; Chiumello, D.; Ranieri, M.; Quintel, M.; Russo, S.G.; Cornejo, R.; Bugedo, G.; Carlesso, E.; Russo, R.; et al. Lung opening and closing during ventilation of acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 2010, 181, 578–586.
109. Meade, M.O.; Cook, D.J.; Guyatt, G.H.; Slutsky, A.S.; Arabi, Y.M.; Cooper, D.J.; Davies, A.R.; Hand, L.E.; Zhou, Q.; Thabane, L.; et al. Ventilation strategy using low tidal volumes, recruitment maneuvers, and high positive end-expiratory pressure for acute lung injury and acute respiratory distress syndrome: A randomized controlled trial. JAMA 2008, 299, 637–645.
110. Lamontagne, F.; Brower, R.; Meade, M. Corticosteroid therapy in acute respiratory distress syndrome. CMAJ 2013, 185, 216–221.
111. Belvitch, P.; Dudek, S.M. Corticosteroids and Ards: The debate continues. Crit. Care Med. 2013, 41, 1813–1814.
112. Thompson, B.T. Corticosteroids in Ards. N. Engl. J. Med. 2006, 355, 316–319.
113. Greaves, M.W. Anti-inflammatory action of corticosteroids. Postgrad. Med. J.1976, 52, 631–633.
114. Rhen, T.; Cidlowski, J.A. Antiinflammatory action of glucocorticoids—New mechanisms for old drugs. N. Engl. J. Med. 2005, 353, 1711–1723.
115. Meduri, G.U.; Marik, P.E.; Chrousos, G.P.; Pastores, S.M.; Arlt, W.; Beishuizen, A.; Bokhari, F.; Zaloga, G.; Annane, D. Steroid treatment in Ards: A critical appraisal of the Ards network trial and the recent literature. Intensive Care Med. 2008, 34, 61–69.
116. Tang, B.M.; Craig, J.C.; Eslick, G.D.; Seppelt, I.; McLean, A.S. Use of corticosteroids in acute lung injury and acute respiratory distress syndrome: A systematic review and meta-analysis. Crit. Care Med. 2009, 37, 1594–1603.
117. Steinberg, K.P.; Hudson, L.D.; Goodman, R.B.; Hough, C.L.; Lanken, P.N.; Hyzy, R.; Thompson, B.T.; Ancukiewicz, M. Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N. Engl. J. Med. 2006, 354, 1671–1684.
118. Bernard, G.R.; Luce, J.M.; Sprung, C.L.; Rinaldo, J.E.; Tate, R.M.; Sibbald, W.J.; Kariman, K.; Higgins, S.; Bradley, R.; Metz, C.A.; et al. High-dose corticosteroids in patients with the adult respiratory distress syndrome. N. Engl. J. Med. 1987, 317, 1565–1570.
119. Fyhrquist, F.; Metsarinne, K.; Tikkanen, I. Role of angiotensin II in blood pressure regulation and in the pathophysiology of cardiovascular disorders. J. Hum. Hypertens. 1995, 9 (Suppl 5), S19–S24.
120. Cooper, C.L.; Shaffer, J.E.; Malik, K.U. Mechanism of action of angiotensin ii and bradykinin on prostaglandin synthesis and vascular tone in the isolated rat kidney. Effect of ca++ antagonists and calmodulin inhibitors. Circ. Res. 1985, 56, 97–108.
121. Puscas, I.; Coltau, M.; Gilau, L.; Baican, M.; Pasca, R.; Domuta, G.; Hecht, A. The mechanism of action of angiotensin II is dependent on direct activation of vascular smooth muscle carbonic anhydrase I. Int. J. Clin. Lab. Res. 2000, 30, 119–125.
122. Chawla, L.S.; Busse, L.W.; Brasha-Mitchell, E.; Alotaibi, Z. The use of angiotensin II in distributive shock. Crit. Care 2016, 20, 137.
123. Orfanos, S.E.; Armaganidis, A.; Glynos, C.; Psevdi, E.; Kaltsas, P.; Sarafidou, P.; Catravas, J.D.; Dafni, U.G.; Langleben, D.; Roussos, C. Pulmonary capillary endothelium-bound angiotensin-converting enzyme activity in acute lung injury. Circulation 2000, 102, 2011–2018.
124. Elder, J. The renin-angiotensin system: A potential therapeutic target in Ards? Thorax 2005, 60, 821–821.
125. Zhao, Y.; Zhang, X.; Song, Z.; Qi, D.; Deng, X.; Xia, J.; He, J.; Deng, W.; Zhong, X.; Zhang, C.; et al. Rapamycin Attenuates Acute Lung Injury Induced by Lps through Inhibition of Th17 Cell Proliferation in Mice. Sci. Rep. 2016, 6, 20156.
126. Yang, Q.; Guan, K.L. Expanding Mtor Signaling. Cell Res 2007, 17, 666–681.
127. Powell, J.D.; Pollizzi, K.N.; Heikamp, E.B.; Horton, M.R. Regulation of Immune Responses by Mtor. Annu Rev Immunol 2012, 30, 39–68.
128. Papazian, L.; Forel, J.-M.; Gacouin, A.; Penot-Ragon, C.; Perrin, G.; Loundou, A.; Jaber, S.; Arnal, J.-M.; Perez, D.; Seghboyan, J.-M.; et al. Neuromuscular blockers in early acute respiratory distress syndrome. N. Engl. J. Med. 2010, 363, 1107–1116.
129. Sweeney, R.M.; McAuley, D.F. Acute respiratory distress syndrome. Lancet 2016, 388, 2416–2430.
130. Umbrello, M.; Formenti, P.; Bolgiaghi, L.; Chiumello, D. Current concepts of Ards: A narrative review. Int. J. Mol. Sci. 2017, 18, 64.
131. Dellinger, R.P.; Zimmerman, J.L.; Taylor, R.W.; Straube, R.C.; Hauser, D.L.; Criner, G.J.; Davis, K., Jr.; Hyers, T.M.; Papadakos, P. Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: Results of a randomized phase II trial. Inhaled nitric oxide in Ards study group. Crit. Care Med. 1998, 26, 15–23.
132. Troncy, E.; Collet, J.P.; Shapiro, S.; Guimond, J.G.; Blair, L.; Ducruet, T.; Francoeur, M.; Charbonneau, M.; Blaise, G. Inhaled nitric oxide in acute respiratory distress syndrome: A pilot randomized controlled study. Am. J. Respir. Crit. Care Med. 1998, 157, 1483–1488.
133. Michael, J.R.; Barton, R.G.; Saffle, J.R.; Mone, M.; Markewitz, B.A.; Hillier, K.; Elstad, M.R.; Campbell, E.J.; Troyer, B.E.; Whatley, R.E.; et al. Inhaled nitric oxide versus conventional therapy: Effect on oxygenation in Ards. Am. J. Respir. Crit. Care Med. 1998, 157, 1372–1380.
134. Adhikari, N.K.J.; Burns, K.E.A.; Friedrich, J.O.; Granton, J.T.; Cook, D.J.; Meade, M.O. Effect of nitric oxide on oxygenation and mortality in acute lung injury: Systematic review and meta-analysis. BMJ 2007, 334, 779.
135. Heard, S.O.; Longtine, K.; Toth, I.; Puyana, J.C.; Potenza, B.; Smyrnios, N. The influence of liposome-encapsulated prostaglandin E1 on hydrogen peroxide concentrations in the exhaled breath of patients with the acute respiratory distress syndrome. Anesth. Analg. 1999, 89, 353–357.